Abstract

The use of short acting GnRH agonist to trigger final oocyte maturation in IVF is a common practice. Its primary advantage is prevention of significant ovarian hyperstimulation syndrome. The effect of a long acting GnRH agonist preparation in that setting is not known. In the current case report, a depot preparation was given accidentally, resulting in prolonged and robust luteal phase activity, with luteolysis achieved only 14 days after administration. In that setting, fresh embryo transfer should be avoided.

Highlights

  • To the best of our knowledge, the use of depot GnRH agonist for final oocyte maturation was described only in the context of achieving ovarian suppression before chemotherapy [1]

  • While it was demonstrated that depot GnRH agonist is effective for final oocyte maturation, the luteal phase endocrine profile in general, and the timing of achieving ovarian suppression in particular, are not known

  • We hereby present a case report that confirms that final oocyte maturation can be achieved by depot GnRH agonist administration

Read more

Summary

Introduction

To the best of our knowledge, the use of depot GnRH agonist for final oocyte maturation was described only in the context of achieving ovarian suppression before chemotherapy [1]. While it was demonstrated that depot GnRH agonist is effective for final oocyte maturation, the luteal phase endocrine profile in general, and the timing of achieving ovarian suppression in particular, are not known. We hereby present a case report that confirms that final oocyte maturation can be achieved by depot GnRH agonist administration.

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.